descriptionPublicationkeyboard_double_arrow_right Article 08 Jun 2009 English Publisher:CMA Joule Inc.Journal:Canadian Medical Association Journal, volume 180, pages 1,225-1,226 (issn: 0820-3946, eissn: 1488-2329,

Authors: Baldwin Toye; Milan Fuksa; Sigmund Krajden; Dylan R. Pillai; Donald E. Low;

doi: 10.1503/cmaj.090167

pmid: 19506282

pmc: PMC2691439

Carbapenem resistance in Canada

- Summary
- Subjects
- Metrics

Abstract

For more than 2 decades, carbapenems have been considered the pharmacotherapy of last resort for managing multidrug-resistant infections caused by Enterobacteriaceae bacteria (e.g., Escherichia coli and Salmonella ). Over the past decade, however, resistance to carbapenems has emerged and appears to

Related Organizations

University of Ottawa
Canada
Ottawa Hospital
Canada

Keywords

Canada, Klebsiella pneumoniae, Bacterial Proteins, Carbapenems, Humans, beta-Lactam Resistance, beta-Lactamases, Klebsiella Infections

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	13
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%